|
Brief Reports
Citations 171-180 of 1234 total displayed.
|
Past content
(since Jul 1999):
|
Detection of T lymphocytes with a second-site mutation in skin lesions of atypical X-linked severe combined immunodeficiency mimicking Omenn syndrome
- Taizo Wada, Masahiro Yasui, Tomoko Toma, Yuko Nakayama, Mika Nishida, Masaki Shimizu, Michiko Okajima, Yoshihito Kasahara, Shoichi Koizumi, Masami Inoue, Keisei Kawa, and Akihiro Yachie
Blood 2008; 112: 1872-1875.
[Abstract]
[Full text]
[PDF]
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication
- Susan P. Whitman, Björn Hackanson, Sandya Liyanarachchi, Shujun Liu, Laura J. Rush, Kati Maharry, Dean Margeson, Ramana Davuluri, Jing Wen, Tatiana Witte, Li Yu, Chunhui Liu, Clara D. Bloomfield, Guido Marcucci, Christoph Plass, and Michael A. Caligiuri
Blood 2008; 112: 2013-2016.
[Abstract]
[Full text]
[PDF]
Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl
- Christopher Slape, Leah Y. Liu, Sarah Beachy, and Peter D. Aplan
Blood 2008; 112: 2017-2019.
[Abstract]
[Full text]
[PDF]
mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia
- David T. Teachey, Cecilia Sheen, Junior Hall, Theresa Ryan, Valerie I. Brown, Jonathan Fish, Gregor S. D. Reid, Alix E. Seif, Robin Norris, Yueh J. Chang, Martin Carroll, and Stephan A. Grupp
Blood 2008; 112: 2020-2023.
[Abstract]
[Full text]
[PDF]
Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia
- Stéphanie Dulucq, Stéphane Bouchet, Béatrice Turcq, Eric Lippert, Gabriel Etienne, Josy Reiffers, Mathieu Molimard, Maja Krajinovic, and François-Xavier Mahon
Blood 2008; 112: 2024-2027.
[Abstract]
[Full text]
[PDF]
Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency
- Flavia Guillem, Sarah Lawson, Caroline Kannengiesser, Mark Westerman, Carole Beaumont, and Bernard Grandchamp
Blood 2008; 112: 2089-2091.
[Abstract]
[Full text]
[PDF]
A single nucleotide polymorphism at chromosome 2q21.3 (LCT –13910C>T) associates with clinical outcome after allogeneic hematopoietic stem cell transplantation
- Hanns Hauser, Otto Zach, Otto Krieger, Hedwig Kasparu, Josef Koenig, Michael Girschikofsky, Rainer Oberbauer, and Dieter Lutz
Blood 2008; 112: 2156-2159.
[Abstract]
[Full text]
[PDF]
Expansion of donor-derived hematopoietic stem cells with PIGA mutation associated with late graft failure after allogeneic stem cell transplantation
- Kanako Mochizuki, Chiharu Sugimori, Zhirong Qi, Xuzhang Lu, Akiyoshi Takami, Ken Ishiyama, Yukio Kondo, Hirohito Yamazaki, Hirokazu Okumura, and Shinji Nakao
Blood 2008; 112: 2160-2162.
[Abstract]
[Full text]
[PDF]
Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia
- Mohamad Mohty, Richard M. Szydlo, Agnes S. M. Yong, Jane F. Apperley, John M. Goldman, and Junia V. Melo
Blood 2008; 112: 2163-2166.
[Abstract]
[Full text]
[PDF]
First thalidomide clinical trial in multiple myeloma: a decade
- Frits van Rhee, Madhav Dhodapkar, John D. Shaughnessy, Jr, Elias Anaissie, David Siegel, Antje Hoering, Jerome Zeldis, Bonnie Jenkins, Seema Singhal, Jayesh Mehta, John Crowley, Sundar Jagannath, and Bart Barlogie
Blood 2008; 112: 1035-1038.
[Abstract]
[Full text]
[PDF]
|
|
